[Left ventricular noncompaction: A clinical and morphological study]

L B Mitrofanova1, O M Moiseeva1, D A Khashchevskaya1

  • 1V.A. Almazov Federal Medical Research Center, Saint Petersburg, Russia.

Arkhiv Patologii
|April 13, 2016
PubMed

Insights

Left ventricular noncompaction (LVNC) involves significant noncompacted myocardium and often co-occurs with other cardiomyopathies. Findings suggest hemodynamic and inflammatory factors may influence LVNC development.

Area of Science:

  • Cardiovascular Pathology
  • Histopathology
  • Molecular Cardiology

Context:

  • Left ventricular noncompaction (LVNC) is a rare congenital heart defect characterized by excessive trabeculation.
  • Understanding the diverse morphological spectrum and underlying mechanisms of LVNC is crucial for diagnosis and management.

Purpose:

  • To comprehensively analyze the clinicopathological features of left ventricular noncompaction (LVNC).
  • To investigate the association of LVNC with other cardiac pathologies and potential genetic factors.
  • To correlate magnetic resonance imaging (MRI) findings with morphological data in LVNC patients.

Summary:

  • Analysis of 7 LVNC patient hearts revealed a predominant noncompact layer, myocardial hypertrophy, fibrosis, and endocardial fibroelastosis in most cases.
  • Associated findings included right ventricular hypertrabeculation, myocarditis, lipomatosis, and altered connexin 43 expression.
  • Morphological findings aligned with MRI in 100% of cases, showing overlapping features with restrictive, hypertrophic, and dilated cardiomyopathies.

Impact:

  • This study elucidates the complex histopathological landscape of LVNC, highlighting its frequent coexistence with other cardiomyopathies.
  • The findings suggest that hemodynamic and inflammatory factors may play a significant role in the pathogenesis of the LVNC phenotype.
  • Provides valuable insights for differential diagnosis and understanding the multifactorial etiology of LVNC.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
652
Mitral Stenosis II: Clinical features and Diagnostic Tests01:23

Mitral Stenosis II: Clinical features and Diagnostic Tests

Mitral stenosis is a heart condition in which the mitral valve, which allows blood to flow from the left atrium to the left ventricle, becomes narrowed or stenotic. This narrowing hinders blood flow and leads to clinical symptoms requiring specific medical evaluations and management strategies. The following overview outlines the clinical symptoms, assessments, diagnostic findings, prevention methods, and treatments for mitral stenosis.Clinical ManifestationsDyspnea (shortness of breath): This...
402
Aortic Regurgitation II: Clinical Features and Diagnostic Tests01:22

Aortic Regurgitation II: Clinical Features and Diagnostic Tests

Aortic valve regurgitation (AR) occurs when the aortic valve fails to close properly, allowing blood to flow backward from the aorta into the left ventricle. This backflow can result in two distinct clinical presentations: acute and chronic AR, each characterized by its own set of symptoms and physical findings.Acute Aortic RegurgitationAcute AR presents with a sudden onset of severe symptoms. Patients typically experience profound dyspnea (shortness of breath), chest pain, and signs of left...
834